Four Sigmatic Debuts The Last of Us Organic Ground Coffee, Infected with Focus & Energy

Four Sigmatic

Four Sigmatic, the #1 functional coffee brand, announced the debut of The Last Of Us High Caffeine Organic Ground Coffee in collaboration with Sony Pictures Consumer Products. Four Sigmatic’s The Last of Us coffee is crafted with organic Arabica coffee, cordyceps (not mutated!) and lion’s mane mushrooms, vitamin B12, and coffee bean extract for infectious […]

CereVasc’s eShunt® System Gains FDA Breakthrough Designation

“The recognition of Breakthrough Device Designation for the eShunt System in pediatric aged patients demonstrates the profound need for treatment innovation in this patient population and reinforces the potential safety and efficacy benefits that have already been observed with this minimally invasive, endovascular approach,” said Dan Levangie, Chairman & CEO of CereVasc, Inc. “We are encouraged and committed to making the eShunt System available to as many patients as possible living with this debilitating disease.”

Efemoral Medical Releases Positive Long-Term Results from EFEMORAL I

“The EVSS represents a new paradigm in peripheral interventions,” said Christopher Haig, Co-Founder and CEO of Efemoral Medical. “It’s easy to deploy, has high radial strength, can be made in longer lengths, and offers the promise of durable outcomes without the need for a permanent implant.”

Adventist HealthCare Emergency Departments Launch AI Initiative to Help Enhance Patient Safety and Care Efficiency

The software, KATE AI, is helping care teams ensure the safety and consistency of triage at Adventist HealthCare Shady Grove Medical Center, Adventist HealthCare White Oak Medical Center and Adventist HealthCare Fort Washington Medical Center. Emergency teams at the hospitals are using KATE AI to help verify care plans for patients who are at higher risk or have more complex conditions.

R3 Vascular Announces First Patient Treated in ELITE-BTK Pivotal Trial for Below-the-Knee PAD Using MAGNITUDEÒ Drug Eluting Bioresorbable Scaffold

The trial evaluates R3 Vascular’s next-generation drug-eluting bioresorbable scaffold, MAGNITUDE®, for below-the-knee (BTK) PAD, which according to the American Heart Association affects more than 200 million people globally, and 10 to 12 million in the U.S. older than the age of 40.  The most common type of PAD affects the lower-extremity where blood flow is reduced to the legs and feet.  Each year, approximately 150,000 leg amputations are performed in the U.S. alone.      

Climate-Controlled Field Hospitals: Protecting Patients in Extreme Environments

Climate-Controlled Field Hospitals

Climate-controlled field hospitals have emerged as critical innovations in humanitarian response, military operations, and disaster relief efforts. These sophisticated temporary facilities enable healthcare delivery in environments where temperatures soar above 120°F or plummet below freezing, where sandstorms rage, or where monsoon rains threaten to wash away conventional tents.